Remepy
Found 2 recent publications
Aug 12, 2026
17:06
+
Startups
$36 million for the Israeli startup that connects drugs with code
Israeli startup Remepy has raised $36 million in a Series A funding round. The company is developing "hybrid drugs" that combine traditional medication with digital code to enhance treatment efficacy.
15:43
+
Startups
Michal Tsur's startup Remepy raises $36 million for the development of hybrid drugs
Remepy has raised $36 million in a Series A funding round. The startup develops hybrid drugs that combine prescription medication with AI-based therapeutic applications.
Showing latest 50 articles for this tag